OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?
João Carlos Locatelli, Juliene Gonçalves Costa, Andrew Haynes, et al.
Diabetes Care (2024) Vol. 47, Iss. 10, pp. 1718-1730
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S86-S127
Closed Access | Times Cited: 22

8. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes–2025
Nuha A. ElSayed, Rozalina G. McCoy, Grazia Aleppo, et al.
Diabetes Care (2024) Vol. 48, Iss. Supplement_1, pp. S167-S180
Closed Access | Times Cited: 20

The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation
Konstantinos Stefanakis, Michail Kokkorakis, Christos S. Mantzoros
Metabolism (2024), pp. 156057-156057
Closed Access | Times Cited: 15

Effects of liraglutide on body composition in people living with obesity or overweight: A systematic review
P Schmidt, Eric Pasqualotto, Henrique Vilar Dos Santos, et al.
Obesity Research & Clinical Practice (2025)
Closed Access | Times Cited: 1

Impact of BMI Reduction After Sleeve Surgery on ESR and CRP Levels in Patients with Obesity
Faraneh Farsad, Sara Salimpour, Seyedhadi Mirhashemi, et al.
Obesity Surgery (2025)
Closed Access | Times Cited: 1

Diabetes, obesity, and cardiovascular disease—what is the impact of lifestyle modification?
Celina Seth, Veronika Schmid, Stephan Mueller, et al.
Herz (2025)
Closed Access | Times Cited: 1

Interplay of Chronic Kidney Disease and the Effects of Tirzepatide in Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
Milton Packer, Michael R. Zile, Christopher M. Kramer, et al.
Journal of the American College of Cardiology (2025)
Open Access | Times Cited: 1

Consensus on the key characteristics of metabolism disruptors
Michele A. La Merrill, Martyn T. Smith, Cliona M. McHale, et al.
Nature Reviews Endocrinology (2024)
Open Access | Times Cited: 5

The Role of Exercise in Steatotic Liver Diseases: An Updated Perspective
Iyiad Alabdul Razzak, Ahmed Fares, Jonathan G. Stine, et al.
Liver International (2024) Vol. 45, Iss. 1
Closed Access | Times Cited: 5

Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomes
Thomas Först, Christophe De Block, Stefano Del Prato, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access

Diabetes and Sarcopenia: Intersection of Co Morbid Conditions
Byron J. Hoogwerf
OBM Geriatrics (2025) Vol. 09, Iss. 01, pp. 1-23
Open Access

Therapeutic Potential of GLP-1 Receptor Agonists in Metabolic Associated Steatotic Liver Disease
Klaudia Nowak, Krzysztof Łupina, Anna Romac, et al.
Annals of Pharmacotherapy (2025)
Closed Access

Effect of Hypoglycemic Drugs on Patients with Heart Failure with or without T2DM: A Bayesian Network Meta-analysis
Zhaolun Zhang, Su‐Hsun Liu, Jiawen Xian, et al.
Reviews in Cardiovascular Medicine (2025) Vol. 26, Iss. 3
Open Access

Exercise for Postmenopausal Bone Health – Can We Raise the Bar?
Shejil Kumar, Cassandra Smith, Roderick Clifton‐Bligh, et al.
Current Osteoporosis Reports (2025) Vol. 23, Iss. 1
Open Access

Gut microbes-muscle axis in muscle function and meat quality
Yiwen He, Hong Hu, Xuemei Liang, et al.
Science China Life Sciences (2025)
Closed Access

Efectividad de la liraglutida en el tratamiento de la obesidad del adolescente
Mónica Ruiz Pons, Mateus Martins Cortez Vilar, C Zurita, et al.
Anales de Pediatría (2025), pp. 503856-503856
Open Access

Sarcopenic obesity and weight loss-induced muscle mass loss
Alfredo Caturano, Anastassia Amaro, Cesare Berra, et al.
Current Opinion in Clinical Nutrition & Metabolic Care (2025)
Closed Access

CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes
Oliver Schnell, Jaime P. Almandoz, Lisa Anderson, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access

Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure
Winston Wang, Danielle B. Green, Hoang Nhat Pham, et al.
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1108-1108
Open Access

Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Qiuxia Jiao, Yuan Huang, Jinhan He, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 238-238
Open Access

Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults
Marco Infante, F Silvestri, Nathalia Padilla, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1303-1303
Open Access

Page 1 - Next Page

Scroll to top